Topic: Synteract - Sponsored

With 800 staff members across 21 countries, Synteract is an innovative, full-service contract research organization supporting biopharmaceutical companies in all phases of clinical development to help bring new medicines to market. Synteract has conducted nearly 4,000 studies on six continents and in more than 60 countries, and contributed to more than 240 product approvals. The CRO offers a notable depth of expertise in oncology - including extensive immunotherapy experience - as well as pediatric, neuro degenerative indications, rare and orphan, and others. Learn more at